Next-Generation Sequencing The latest news on next-generation sequencing. Aug 24, 2022 Myriad Genetics, Clarified Precision Medicine Team up on Molecular Tumor Board Service Aug 12, 2022 AstraZeneca, Daiichi Sankyo's Enhertu Scores FDA Accelerated Approval in HER2-Mutant Lung Cancer Aug 8, 2022 CAP Weighs in on dMMR, MSI Assays for Immunotherapy Patient Selection Premium Jul 28, 2022 Canadian Nurse Navigator-Led Program Aims to Improve Breast Cancer Genomic Test Access Premium Jul 21, 2022 Survey Shows Half of Doctors Consider MRD Status When Treating Multiple Myeloma Patients Premium Jul 19, 2022 Geneseeq, Brazil’s Hospital de Base Partner to Build Sequencing Lab for Cancer Patient Testing Jul 15, 2022 Almac, AstraZeneca CDx Partnership Branching Out to New Disease Areas, Drawing on NGS, qPCR Premium Jul 14, 2022 Synthetic Control Arms Finding Stronger Footing in Precision Oncology Trials, Regulatory Submissions Premium Jul 13, 2022 Faeth Therapeutics Wants to Starve Tumors to Death on Precision Diet Premium Jul 13, 2022 Oncologists Seeing Lack of PARP Inhibitor Response in MSI-High, BRCA-Mutant Prostate Cancer Patients Jul 12, 2022 NCCN Publishes First Guidelines for Pediatric Brain Cancer, Recommends Broad NGS Profiling Jul 7, 2022 Calithera Biosciences Begins Phase II Study of Sapanisertib for Advanced NRF2-Mutant NSCLC Jun 30, 2022 CMS Retains Unspecified Cancer Dx Codes After Industry Stakeholder Feedback Premium Jun 29, 2022 Sarcoma Patients Should Receive Genomic Profiling More Often, Research Suggests Premium Jun 22, 2022 European Commission Approves Novartis MET Inhibitor Tabrecta for Advanced NSCLC Jun 15, 2022 Imagia Canexia Health Garners CE-IVD Mark for Comprehensive Cancer Testing Platform Jun 9, 2022 Tempus, Lilly Ink Partnership to Offer No-Cost NGS for Advanced NSCLC Patients Jun 8, 2022 Oncology Pharmacist Helps Boost Patient Enrollment at Community Practices Engaging in MYLUNG Study Jun 1, 2022 Burning Rock, Stratipath, Genetron Receive CE Marks for Cancer Tests May 18, 2022 BC Platforms, Euformatics, Oncompass to Develop Oncology NGS Workflows for European Hospitals Load More Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week: Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
